Share Twitter LinkedIn Facebook Email Hans Hammers, MD, PhD, Associate Professor, UT Southwestern takes the pro stance during a debate on IO/IO in 1st Line at the 13th European International Kidney Cancer Symposium 2018 in Prague.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read